Brand profile · Biotechnology Research

CytoMed Therapeutics Limited

CytoMed Therapeutics Limited is a Biotechnology Research brand in Singapore. Ownership is publicly held; it publishes at cytomed.sg. It holds one address on record, all in Singapore. The record counts 26 people. One Singapore registration (UEN) is a candidate match. It is listed alongside three similar brands, mostly in Biotechnology Research.

Profile live Public Company Founded 2018 1 registry match UEN 1 office country
Registry match · ACRA

Key facts

Counted staff
26
self-reported 11–50 band
Founded
2018
8 years
Registry matches
1
ACRA
Office countries
1
1 address
Funding rounds
None on record
Company type
Public Company
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 possible registrationThese are name matches on ACRA. 1 registration share this brand's name; which one you contract with is a question for the register.
  • CYTOMED THERAPEUTICS LIMITED

    UEN201808327H

    Medium confidenceMatched on exact nameACRA

Legal entities

CytoMed Therapeutics Limited: 1 registry entityCytoMed Therapeutics Limited is linked to 1 registry entity: CYTOMED THERAPEUTICS LIMITED (UEN 201808327H, candidate).CytoMed Therapeutics LimitedCYTOMED THERAPEUTICSLIMITEDUEN 201808327HCandidate · Medium confidence
Show as table · CytoMed Therapeutics Limited: 1 registry entity
CytoMed Therapeutics Limited: 1 registry entity
CYTOMED THERAPEUTICS LIMITEDUEN 201808327H
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Incorporated in 2018, CytoMed Therapeutics (NASDAQ: GDTC) was spun off from the Agency for Science, Technology and Research (A*STAR), Singapore’s national research and development agency in the public sector. CytoMed is a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel, allogenic off-the-shelf cellular immunotherapies for the treatment of human cancers, both liquid and solid tumors. The development of novel technologies has been inspired by the clinical success of existing CAR-T in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into treatment of solid tumors. The leading CAR-γδ T cell technology, CMT-N2D therapy, is now a clinical trial-ready product set to begin Phase 1 clinical trials.

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary SG. Codes: SG.1 countryprimary SGSG
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countrySG

All codes: SG

Addresses

  • SG1 Commonwealth Ln, #08-22; Singapore, 149544Primary

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under CytoMed Therapeutics Limited?

One Singapore entity on ACRA. CYTOMED THERAPEUTICS LIMITED (UEN 201808327H), medium confidence.

How many people work at CytoMed Therapeutics Limited?

The record holds 26 counted staff profiles at January 2026, inside the self-reported 11–50 band.

Where does CytoMed Therapeutics Limited have offices?

One address on record, Singapore only. Primary: 1 Commonwealth Ln, #08-22, Singapore 149544.

Has CytoMed Therapeutics Limited raised funding?

None linked to this brand.

Which companies are listed alongside CytoMed Therapeutics Limited?

3 profiles list CytoMed Therapeutics Limited as a peer — 49th percentile in Biotechnology Research. It lists ten peers of its own. Singzyme lists it back.

What is CytoMed Therapeutics Limited's website?